New and old technologies for organ replacement

被引:19
作者
Platt, Jeffrey L. [1 ,2 ]
Cascalho, Marilia [1 ,2 ]
机构
[1] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA
基金
美国国家卫生研究院;
关键词
embryonic stem cells; organ allocation; organogenesis; pluripotent stem cells; xenotransplantation; PLURIPOTENT STEM-CELLS; HEPATOCYTE-LIKE CELLS; LIVER-TRANSPLANTATION; NUCLEAR TRANSFER; HEART-FAILURE; SOMATIC-CELLS; DIFFERENTIATION; KIDNEY; XENOTRANSPLANTATION; GENERATION;
D O I
10.1097/MOT.0b013e32835f0887
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Purpose of review The demand for organ transplantation has increased over time, increasingly exceeding the supply of organs. Whether and how new or old technologies separately or together could be applied to replacing organs will thus remain a question of importance. Recent findings Estimating how the demand for organ transplantation will evolve over the decades and the need to bring forward and test new technologies will help establish the dimensions of the problem and the priorities for investigation. Pluripotent stem cells can in principle expand to sufficient numbers, differentiate, and assemble complex and functional organs. However, the devising of effective and reliable means to coax the stem cells to do so remains beyond the current grasp. Summary Given the time during which novel therapies are devised and applied, which organ transplantation reaches to 2-3 decades, one can anticipate the need for organ replacement will grow dramatically, but advances in science and technology will overcome the hurdles in generating new organs. Whether these advances will address the needs and priorities of society, however, is unclear.
引用
收藏
页码:179 / 185
页数:7
相关论文
共 58 条
[1]   Reversal of hyperglycemia in diabetic mouse models using induced-pluripotent stem (iPS)-derived pancreatic β-like cells [J].
Alipio, Zaida ;
Liao, Wenbin ;
Roemer, Elizabeth J. ;
Waner, Milton ;
Fink, Louis M. ;
Ward, David C. ;
Ma, Yupo .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (30) :13426-13431
[2]  
[Anonymous], GUID HUM EMBR STEM C
[3]   RETRACTED: Regenerating new heart with stem cells (Retracted Article) [J].
Anversa, Piero ;
Kajstura, Jan ;
Rota, Marcello ;
Leri, Annarosa .
JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (01) :62-70
[4]   RETRACTED: Engineered whole organs and complex tissues (Retracted article. See vol. 392, pg. 11, 2018) [J].
Badylak, Stephen F. ;
Weiss, Daniel J. ;
Caplan, Arthur ;
Macchiarini, Paolo .
LANCET, 2012, 379 (9819) :943-952
[5]   Whole-Organ Tissue Engineering: Decellularization and Recellularization of Three-Dimensional Matrix Scaffolds [J].
Badylak, Stephen F. ;
Taylor, Doris ;
Uygun, Korkut .
ANNUAL REVIEW OF BIOMEDICAL ENGINEERING, VOL 13, 2011, 13 :27-53
[6]   Change in Mortality from Coronary Heart Disease and Stroke in Arkansas (1979 to 2007) [J].
Balamurugan, Appathurai ;
Mehta, Paulette ;
Bates, Joseph ;
Mehta, Jawahar L. .
AMERICAN JOURNAL OF CARDIOLOGY, 2011, 107 (02) :156-160
[7]   Inducing iPSCs to Escape the Dish [J].
Barrilleaux, Bonnie ;
Knoepfler, Paul S. .
CELL STEM CELL, 2011, 9 (02) :103-111
[8]   Stem cells assessed [J].
Blanpain, Cedric ;
Daley, George Q. ;
Hochedlinger, Konrad ;
Passegue, Emmanuelle ;
Rossant, Janet ;
Yamanaka, Shinya .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2012, 13 (07) :471-476
[9]   Sheep cloned by nuclear transfer from a cultured cell line [J].
Campbell, KHS ;
McWhir, J ;
Ritchie, WA ;
Wilmut, I .
NATURE, 1996, 380 (6569) :64-66
[10]  
Carstea Ana Claudia, 2009, World J Stem Cells, V1, P22, DOI 10.4252/wjsc.v1.i1.22